Treatment
Treatment literacy materials that cover the basics of hepatitis C treatment, research on efficacy in different key populations, and global treatment uptake.
Materials in this section
Artificial Intelligence-Assisted Identification and Retrieval of HCV Patients Lost to Follow-up in Spain
A study identified and relinked to care HCV patients previously lost to medical follow-up in Spain using an artificial intelligence-assisted system. More
Staff-Facilitated Telemedicine Care Delivery for Treatment of Hepatitis C among People Who Inject Drugs
A study measures the acceptability, feasibility, and safety of an urban point-of-diagnosis HCV treatment initiation approach delivered in a non-clinical community setting, through a novel staff-facilitated telemedicine model. More
Model Says Treating Only 75 of 1000 PWID Would Eliminate HCV in This Group
If at least 7.5% of people who inject drugs in the Chicago area use direct-acting antivirals, HCV would be eliminated from that population in 10 years. More
Advancing Hepatitis C Treatment in Sub-Saharan Africa
Findings from the TAC ANRS 12311 trial revealed the success of tailored treatment combinations to the specific genotype of HCV to optimize efficacy and minimize adverse effects. More
Increased Social Support Linked to HCV Status Awareness, Treatment Uptake
Access to care, health insurance, and social support systems were associated with increased hepatitis C virus awareness and treatment among individuals with a history of injection drug use. More
JAMA Paper: In People with Opioid Use Disorder, Telemedicine Treatment for HCV Was More Than Twice as Successful as Off-Site Referral
The study is one of only a few randomized controlled trials that have been conducted to determine the effectiveness of using telemedicine to improve health care access for vulnerable populations. More
Rapid Communication: Co-Administration of Treatment for Drug-Resistant TB and Hepatitis C
WHO announces forthcoming updates on co-administration of treatment for drug-resistant TB and hepatitis C. More
Telemedicine at Syringe Access Programs May Address Barriers, Expand Access to HCV Treatment
A survey found telemedicine-based HCV treatment at a syringe access program could improve access to treatment among people who inject drugs. More
Self-Reported and Objective Compliance for HCV Treatment Reflect Different Cure Rates
Study exposes the adherence gap in HCV direct-acting antiviral therapy among people who inject drugs. More
People Who Inject Drugs Report Unique Barriers to Hepatitis C Treatment
A Toronto study analyzes differences in hepatitis C treatment experiences based on drug use. More
